semaglutide for pain Ozempic (semaglutide), a medication FDA-approved type 2 diabetes and chronic weight management, is increasingly being discussed by people living with endometriosis. While not approved to treat the condition, we know that Does Ozempic cause Joint Pain?

Optimise protein intake: Adequate dietary protein is fundamental to muscle preservation

Base Value(2026): 2.5 Bn Estimated Value(2026): 2.5 Bn Forecast Value (2036): 9.0 Bn CAGR (2026 - 2036): 13.7% GLP-1 Obesity Home Delivery Injectables Market Forecast and Outlook 2026 to 2036 The global market for GLP-1 obesity home delivery injectables is projected to total USD 2.49 billion in 2026, advancing to USD 9.04 billion by 2036

Analysts expect this markets value to grow by 2.6x in the coming years, reaching global sales of nearly US$140 billion by 2030

The 2012 New England Compounding Center outbreak documented what happens when even professional compounding environments fall short of sterility standards contaminated injectable methylprednisolone resulted in 751 fungal infections and 64 deaths across 20 states

Retatrutide: Designed to Last One of the newest GLP-1 medications in development is retatrutide , a triple agonist (GLP-1, GIP, and glucagon receptors) designed with an approximate 6-day half-life , thanks to advanced pharmaceutical engineering